Clients

Arch Therapeutics, Inc.

Company Snapshot: Arch Therapeutics, Inc.

ARTH
Last Change Volume High Low

Company Overview

Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate, known as AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures.

Featured Documents

Client News

  1. Jul 20 2018 Arch Therapeutics Appoints Healthcare Industry Executive Punit Dhillon to Board of Directors
  2. Jun 29 2018 Arch Therapeutics, Inc. $4.5 Million Registered Direct Offering
  3. Jun 26 2018 Arch Therapeutics Provides Skin Sensitization Study Status Update
  4. Jun 15 2018 Arch Therapeutics Completes Enrollment and Initiates Dosing in Skin Sensitization Study